Social stress and the inflamed brain
Inflammatory factors in the brain may hold the key to depression-cardiovascular disease comorbidity
2013-04-21
(Press-News.org) BOSTON — Depression is the leading cause of disability with more than 350 million people globally affected by this disease. In addition to debilitating consequences on mental health, depression predisposes an individual to physiological disease such as heart disease, and conversely heart disease increases the risk of depression. According to the World Health Organization by the year 2020 heart disease and depression will be the number one and number two leading causes of disability in developed countries. While the co-occurrence of these disorders is well recognized, an understanding of the underlying mechanisms that lead to this relationship are lacking.
Dr. Susan K. Wood, a Research Associate at the Children's Hospital of Philadelphia, investigates brain-related biomarkers for depression-heart disease comorbidity. She uses a rodent model of social stress likened to bullying in people that she has found to produce depressive-like behaviors and dysfunctional cardiovascular changes in a susceptible subset of rodents. Her previous work highlighted a role for the stress-related neurohormone corticotropin-releasing factor in rendering an individual vulnerable to stress-induced depression and heart disease. Intrigued by what other biomarkers may be distinct her latest study is the first to identify gene and protein expression differences in the brains of rodents that are either vulnerable or resilient to developing stress-induced depressive-like behaviors and cardiovascular dysfunction.
The study, conducted in male rats, compared expression of 88 genes involved in signaling within the brain between socially stressed and non-stressed rats. It revealed more than 35 genes in stressed rats that had altered expression compared with non-stressed controls. Many of the genes that were differentially expressed were related to inflammation. Follow-up studies measuring protein levels revealed that Interleukin-1β and Monocyte chemotactic protein-1, inflammatory markers known to play a role in depression and heart disease, were suppressed in the brains of the resilient subset of rats and Interleukin-1β was increased in the vulnerable group. Dr. Wood measured the gene and protein levels under resting conditions 24 hours after just 5 daily 30-minute exposures to social stress.
The identification of factors in the brain that distinguish susceptibility and resiliency to depression and heart disease comorbidity would be a major advance in predicting, preventing and treating these disorders. Dr. Wood is continuing these studies as an Assistant Professor at the University of South Carolina School of Medicine with the hope that these findings will uncover new targets to treat the mind and body.
Her findings will be presented April 21st, 2013 during Experimental Biology 2013 in Boston, MA.
###
To request an interview with Dr. Wood, please contact Jim Bernstein at the contact information listed above.
About Experimental Biology 2013
Experimental Biology's mission is to share the newest scientific concepts and research findings shaping future and current clinical advances – and to give scientists and clinicians an unparalleled opportunity to hear from colleagues working on similar biomedical problems using different disciplines. With six sponsoring societies and another 20 U.S. and international guest societies, the annual meeting brings together scientists from throughout the United States and the world, representing dozens of scientific areas, from laboratory to translational to clinical research. The meeting also offers a wide spectrum of professional development sessions.
About the American Society for Pharmacology and Experimental Therapeutics
ASPET is a 5,100 member scientific society whose members conduct basic and clinical pharmacological research within the academic, industrial and government sectors. Our members discover and develop new medicines and therapeutic agents that fight existing and emerging diseases, as well as increase our knowledge regarding how therapeutics affects humans.
END
ELSE PRESS RELEASES FROM THIS DATE:
2013-04-21
Geneva, Switzerland: Unavoidable damage caused to the heart and lungs by radiotherapy treatment of tumours in the chest region can be limited by the administration of an ACE inhibitor, a drug commonly used in the treatment of cardiovascular disease, a group of Dutch researchers have found. [1]
Common cancers such as breast, oesophagus, lung, and Hodgkin's lymphoma are frequently treated with radiotherapy, but the radiation dose that can be given safely is limited by the sensitivity of the health lung tissue which is also irradiated.
The lung is a particularly complex ...
2013-04-21
Middle school students from rural Maine will present a poster at the Experimental Biology 2013 conference detailing how their involvement with the Aspirnaut science-outreach program led to them becoming active scientific researchers.
Students from the Dedham School in Dedham, Maine, were participants in the Aspirnaut program (http://www.aspirnaut.org), a science-outreach program started at Vanderbilt University, in which scientists engage with middle- and high-school students through videoconferencing. Showing a great interest in the research that was being demoed by ...
2013-04-21
Geneva, Switzerland: Intensity modulated radiotherapy (IMRT) gives better results than standard radiotherapy in patients with early breast cancer, according to results from a randomised trial presented today (Sunday) to the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO). IMRT is an advanced, high-precision form of radiotherapy that can deliver an even dose of radiation, thus reducing the cosmetic problems that can often occur after breast radiotherapy.
"We believe that this study, the largest prospective trial in the world to test breast IMRT ...
2013-04-21
Lisa B. Overton is opening up and telling the world about her life as the child of a forbidden love affair. This moving story details her experience growing up as the child of a Roman Catholic priest and an ex-nun who entered into a 30+ year clandestine love affair.
She tells the poignant story of her childhood and how she survived loneliness, shame and hypocrisy in her parents' painful and secretive shadow and how she eventually forgave them both. She never knew who her father was until finally, on her mother's death bed Lisa asked, "Was Uncle my father?" ...
2013-04-21
Brene Brown will be the featured speaker at the University of Houston Graduate College of Social Work (GCSW) inaugural scholarship luncheon, "Daring to Soar," at 11:30 a.m., Wednesday, May 8 at the Houston Country Club.
For more than a decade, Brown has been researching and writing about shame, vulnerability, courage and compassion in her role as a research professor at the UH GCSW. Her latest milestone was a two-episode appearance with celebrated talk show host Oprah Winfrey to discuss Brown's new book, "Daring Greatly," which made its way onto ...
2013-04-21
On Monday, April 29th 2013 the 14th annual Newport Beach Film Festival will present its Australian Spotlight, an evening celebration of Australian cinema and culture. The event will feature the West Coast Premiere of the highly anticipated film, Drift, followed by a festive post screening gala.
Drift is an action-packed ride that reflects the dynamic surf culture and spirit that is shared by Austrialia and southern Califoria. The film, based on a true story, follows two brothers (Absolut Vodka and Stella Artois Beer, 10 top Orange County restaurants serving signature ...
2013-04-21
Dallas is recognizing Architecture Month in April with a challenge to architects, design professionals and amateur urbanites around the world to share ideas and devise solutions for one of the city's oldest and most vexing development hurdles, according to guests on the most-recent segment of the KRLD 1080 AM "Pulse of the City" radio show, sponsored by the Dallas law firm Munck Wilson Mandala.
The Connected City Design Challenge seeks new strategies for connecting and unifying Downtown Dallas with the extensive development underway along the Trinity River. ...
2013-04-21
On Tuesday, April 16, 2013, Mr, Lichtenstein's firm obtained a 2.1 Million Dollar verdict in a Brachial Plexus/ Erb's Palsy case tried in Cooperstown, New York, Brandenburg v. Bassett Hospital.
After prosecuting the case for many years, Mr. Lichtenstein retained Christina M. Sonsire, a highly gifted medical malpractice lawyer in Elimria New York, as trial counsel As Ms. Sonsire stated that "The tremendous outcome of this trial was the result of a true team effort. She noted that Mr. Lichtenstein was involved in every step of the trial process and that his "depth ...
2013-04-21
After an extensive absence from the music industry as promoter of best-selling gospel-jazz recording artist and ex-husband, Ben Tankard and gospel diva, Yolanda Adams and others, Ms. Tankard-Nichols chose to keep a low profile by using the name Benita Savage Nichols to keep in touch with her family, friends, and associates in the gospel music industry and film biz.
According to Ms. Tankard-Nichols, the organization exists for the healing, restoration, and salvation of God's people. She states, "We are a catalyst for end time Revival throughout the Nations of the ...
2013-04-21
The William & Mary Board of Visitors voted unanimously to approve an expanded mission and a new vision and strategic plan for Richard Bland College at their meeting in Williamsburg on Friday, April 19th. The William & Mary Board last approved a strategic plan for Richard Bland in 1997.
President Debbie L. Sydow, Ph.D. led development of the new plan, titled RBC-19, which affirms the university transfer mission and, in addition, seeks to expand access to college credentials through strategic partnerships, specialized programming and scalable innovation. The Board, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Social stress and the inflamed brain
Inflammatory factors in the brain may hold the key to depression-cardiovascular disease comorbidity
